Roche Holding said its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, bolstering the Swiss drugmaker’s defense against a wave of cut-price competition to its top-selling medicines.

Sections:  world   
Topics:  europe   
RELATED ARTICLES
BING NEWS:
  • Roche's Immunotherapy Drug Tecentriq Extended Patients' Lives in Study
    Roche Holding AG said Thursday that its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, offering a new hope for patients and bolstering the Swiss drugmaker's defense against a wave ...
    12/6/2017 - 12:14 pm | View Link
  • Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA
    Tecentriq in May 2016 for the treatment of patients suffering from locally advanced or metastatic urothelial carcinoma. Initial uptake of the drug has been encouraging. In October 2016, Tecentriq became the first and only anti-PDL1 cancer immunotherapy to ...
    09/17/2017 - 6:59 pm | View Link
  • Press Release: CHMP Recommends EU Conditional Approval of Roche's Alecensa (alectinib) for People With Previously Treated ALK-Positive NSCLC
    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency (EMA) for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the use of Alecensa® (alectinib) for the treatment of adult patients with advanced ...
    12/16/2016 - 4:13 am | View Link
  • NHS patients barred from BMS' Opdivo, Roche's Kadcyla
    NICE is planning to bar patients with a particular form of lung cancer from access to Bristol-Myers Squibb’s ground-breaking immunotherapy Opdivo on the ... the Early Access to Medicines Scheme. The drug’s innovative mode of action works by harnessing ...
    12/15/2015 - 5:45 pm | View Link
  • More
BING SEARCH:
  • Pharm Exec's 2016 Pipeline Report | Pharmaceutical Executive
    Falling enterprise values and the drug pricing controversy have defined the life sciences landscape during the waning days of 2015. Casey McDonald reports.
    01/9/2018 - 3:47 pm | View Website
  • Roche Holding AG ADR
    Roche Holding AG ADR stock price, stock quotes and financial overviews from MarketWatch.
    01/9/2018 - 7:40 am | View Website
  • Today's Stock Market News and Analysis
    Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more.
    01/8/2018 - 12:42 pm | View Website
  • AFSPA
    Latest news from AFSPA on Federal Employees Health ... On Dec. 20, 2017, the U.S. Food and Drug Administration (FDA) approved Merck and Pfizer’s Steglatro ...
    01/8/2018 - 4:06 am | View Website
  • AMGN Stock Price
    Amgen beats EPS, sales revenue, increases guidance. Shares of Amgen Inc. rose 1% late Wednesday after the biotech drug maker reported third-quarter earnings above ...
    01/8/2018 - 2:47 am | View Website
  • More